300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Facebook
Blockchain
B2B
Social Network
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Construction
Automotive
Legal
Sports
eSports
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Theatre
Recruiting
Crowdfunding
Web3
Medical
Fashion
Social
Venture Capital
Infrastructure
Beauty
Celebrity
Cannabis
Climate
LGBT
Publishing
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Music
Real Estate
Art
Sporting Goods
Digital Media
Finance
Manufacturing
FinTech
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Biotech
Proptech
Sustainability
Hardware
Transportation
Impact
Enterprise
Community
Media (Entertainment)
Any country
Burkina Faso
South Korea
Africa
LATAM
Singapore
Brazil
Saudi Arabia
Oceania
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Tunisia
Russian Federation
Togo
Tajikistan
Zimbabwe
Nigeria
Guinea
Nepal
Iran
Kyrgyzstan
Isle of Man
Pakistan
Romania
Colombia
Oman
Cameroon
Australia
New Zealand
China
Sri Lanka
Armenia
Costa Rica
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Malawi
Botswana
Moldova
Seychelles
United Kingdom
Japan
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Poland
Philippines
Portugal
Sierra Leone
Rwanda
El Salvador
Senegal
Thailand
Uruguay
Tanzania
Canada
India
Germany
Ireland
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Europe
Angola
Argentina
Bangladesh
Barbados
Belgium
Ethiopia
Jordan
Austria
Azerbaijan
Ecuador
Bulgaria
Bahrain
Bahamas
Faroe Islands
Jersey
Estonia
Bolivia
Algeria
Belize
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science VC Funds & Investors in United Kingdom (July 2026)

The most active venture capital funds investing in United Kingdom Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in United Kingdom Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Parkwalk Advisors
VC Fund
17 United Kingdom, United States, Philippines Seed, Series A, Series B Biotechnology, Health Care, Software $1.1M–$46M
UK Innovation & Science Seed Fund
VC Fund
14 United Kingdom, United States Seed, Series A Biotechnology, Health Care, Medical $458k–$14M
Oxford Science Enterprises
VC Fund
14 United Kingdom, United States, Finland Seed, Series A, Series B Health Care, Biotechnology, Software $1.3M–$168M
SOSV
VC Fund
13 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
Development Bank of Wales
VC Fund
10 United Kingdom, Australia, United States Seed, Debt Financing Software, Health Care, Biotechnology $18k–$4.1M
IQ Capital
VC Fund
9 United Kingdom, United States, Germany Seed, Series A Software, Artificial Intelligence, Machine Learning $1.3M–$44M
Sofinnova Partners
VC Fund
9 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $6.6M–$109M
GM&C Life Sciences Fund
VC Fund
7 United Kingdom, Italy, Germany Seed, Series A Health Care, Biotechnology, Medical $65k–$4.1M
Selvedge Venture
VC Fund
7 United Kingdom, Singapore Seed, Pre-Seed, Series A Health Care, Biotechnology, Life Science $1.1M–$30M
24 Haymarket
VC Fund
7 United Kingdom, United States Seed, Series A Health Care, Software, Information Technology $714k–$16M
Syncona Partners LLP
VC Fund
7 United Kingdom, United States, Switzerland Series A, Series B, Seed Biotechnology, Medical, Health Care $1.8M–$170M
Techstart Ventures
VC Fund
6 United Kingdom, Ireland, United States Seed, Pre-Seed Software, Information Technology, Health Care $100k–$3.9M
Scottish Enterprise
VC Fund
6 United Kingdom, United States, Switzerland Grant, Seed Biotechnology, Software, Health Care $119k–$4.3M
Kindred Capital
VC Fund
6 United Kingdom, United States, Germany Seed, Series A, Series B Software, Biotechnology, Health Care $1.5M–$73M
Angels in MedCity
VC Fund
6 United Kingdom, United States Seed, Angel Health Care, Biotechnology, Medical $458k–$880k
Future Planet Capital
VC Fund
6 United Kingdom, United States, Spain Seed, Convertible Note Biotechnology, Health Care, Software $670k–$7.3M
Newable Private Investing
VC Fund
6 United Kingdom, United States Seed, Series A Software, Health Care, Biotechnology $196k–$5.2M
Archangels
VC Fund
6 United Kingdom, United States Seed, Series A Software, Health Care, Biotechnology $1.3M–$8.3M
APEX Ventures
VC Fund
5 Germany, United Kingdom, Austria Seed, Series A, Pre-Seed Artificial Intelligence, Software, Health Care $511k–$22M
IP Group
VC Fund
5 United Kingdom, United States, Australia Seed, Series A Health Care, Biotechnology, Therapeutics $393k–$23M
Northstar Ventures
VC Fund
5 United Kingdom, United States, Indonesia Seed, Series A Software, Health Care, E-Commerce $39k–$10M
Scottish Investment Bank
VC Fund
5 United Kingdom, United States, France Seed, Series A Software, Biotechnology, Health Care $327k–$7M
Maven Capital Partners
VC Fund
5 United Kingdom, United States, Germany Seed, Series A Software, Information Technology, SaaS $655k–$25M
Epidarex Capital
VC Fund
5 United Kingdom, United States, Germany Series A, Seed, Series B Biotechnology, Health Care, Therapeutics $531k–$55M
SR One
VC Fund
5 United States, United Kingdom, Canada Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $3.7M–$175M
Deepbridge Capital
VC Fund
5 United Kingdom, Australia, Singapore Seed, Series A Health Care, Biotechnology, Medical $152k–$15M
11.2 Capital
VC Fund
4 United States, Canada, United Kingdom Seed, Series A, Series B Software, Information Technology, Biotechnology $1M–$53M
AlbionVC
VC Fund
4 United Kingdom, United States, France Series A, Seed Software, Information Technology, Health Care $2.2M–$20M
Cambridge Innovation Capital
VC Fund
4 United Kingdom, United States, Ireland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2M–$73M
Oxford Capital
VC Fund
4 United Kingdom, United States, France Seed, Series A Software, Health Care, Biotechnology
Google Ventures
VC Fund
4 United States, United Kingdom, Israel Series A, Series B, Seed Software, Health Care, Biotechnology $1.1M–$121M
SFC Capital
VC Fund
4 United Kingdom, United States, Canada Pre-Seed, Seed Artificial Intelligence, Software, Information Technology $127k–$2M
Brandon Capital
VC Fund
4 Australia, United Kingdom, United States Series A, Seed, Series B Biotechnology, Health Care, Medical $673k–$115M
Advent Life Sciences
VC Fund
4 United States, United Kingdom, France Series A, Series B Biotechnology, Health Care, Medical $5.5M–$105M
Angels 5K
VC Fund
4 United Kingdom Seed, Angel Biotechnology, Software, Medical $79k–$1.3M
Playfair Capital
VC Fund
4 United Kingdom, United States, Germany Seed, Series A, Pre-Seed Software, Artificial Intelligence, E-Commerce $700k–$19M
Formic Ventures
VC Fund
4 United States, United Kingdom, Hong Kong Seed, Series A Biotechnology, Health Care, Biopharma $1.3M–$61M
Octopus Ventures
VC Fund
4 United Kingdom, United States, Germany Series A, Seed, Series B Software, Health Care, Artificial Intelligence $2.1M–$48M
Verve Ventures
VC Fund
4 Switzerland, Germany, France Series A, Seed, Series B Health Care, Software, Biotechnology $1.4M–$45M
O2h Ventures
VC Fund
4 United Kingdom, Hungary Seed, Series A Biotechnology, Health Care, Pharmaceutical $603k–$25M
Dementia Discovery Fund
VC Fund
4 United States, United Kingdom, Israel Seed, Series A Biotechnology, Health Care, Therapeutics $5.9M–$77M
Mercia Fund Managers
VC Fund
4 United Kingdom, United States, Hungary Seed, Series A Software, Health Care, Biotechnology $196k–$14M
Beltrae Partners
VC Fund
4 United Kingdom Seed, Series A Health Care, Life Science, Biotechnology
Delin Ventures
VC Fund
4 United Kingdom, Germany, Hungary Seed, Series A, Series B Software, Biotechnology, Information Technology $1.3M–$100M
Molten Ventures
VC Fund
4 United Kingdom, United States, Germany Series A, Series B Software, Information Technology, Financial Services $3.2M–$60M
Ahren Innovation Capital
VC Fund
4 United Kingdom, United States, Israel Series A, Seed, Series B Artificial Intelligence, Biotechnology, Health Care $2.7M–$150M
Catapult Ventures
VC Fund
4 United Kingdom, United States, Israel Seed, Series A Health Care, Biotechnology, Medical $150k–$26M
Northern Gritstone
VC Fund
4 United Kingdom, Singapore Seed, Series A, Series D Software, Electronics, Health Care $2.4M–$229M
Discovery Park
VC Fund
4 United Kingdom, Germany, United States Non-Equity Assistance, Pre-Seed, Seed Biotechnology, Life Science, Energy $391k–$1.7M
Martlet Capital
VC Fund
3 United Kingdom, United States Seed, Series A, Pre-Seed Biotechnology, Software, Health Care
Access all 554 VC funds in United Kingdom Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Parkwalk Advisors
VC Fund · London, England, United Kingdom · 17 investments in United Kingdom Life Science startups

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Philippines

Investor stats

  • Total investments: 277
  • Round size: Seed $1.1M–$5M; Series A $1.6M–$13M; Series B $2M–$46M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • Paragraf — We Work to Develop Innovative and Useful End Products from Novel Materials. Our Analogue Sensors Are Designed to Provide Accurate Field Gradient Mapping & Alignment.
  • Psyomics — Technology to support better mental health assessment - accelerating patients to the right care pathway, first time.
  • PredictImmune — Pragmatic play menciptakan demo slot x500 yang merupakan slot online gratis. Nikmati slot demo pragmatic gacor gampang menang di demo pragmatic jamin gacor.
Show all investments...

UK Innovation & Science Seed Fund
VC Fund · Harwell, Oxfordshire, United Kingdom · 14 investments in United Kingdom Life Science startups

UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 135
  • Round size: Seed $458k–$5.9M; Series A $2.9M–$14M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • MFX — MFX is a platform designed to accelerate the development and manufacturing of cell and gene therapies.
  • Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
  • Hexigone Inhibitors — Hexigone aims to replace toxic chemicals used in the anti-corrosion market with our disruptive, novel, micro/nano reservoir technologies, creating 'smart' coatings. Our additives will enable the coatings to protect for longer in an intelligent manner, increasing the lifetime cycle of the end product, reducing the drain on primaryresources.
Show all investments...

Oxford Science Enterprises
VC Fund · Oxford, Oxfordshire, United Kingdom · 14 investments in United Kingdom Life Science startups

Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Finland

Investor stats

  • Total investments: 177
  • Round size: Seed $1.3M–$12M; Series A $6.3M–$46M; Series B $13M–$168M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely still investing — raised $327M in 2022

Portfolio highlights

  • AlveoGene — Transforming Rare Respiratory Disease Outcomes Using Inhaled Gene Therapy
  • Salience Labs — Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 13 investments in United Kingdom Life Science startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

Development Bank of Wales
VC Fund · Cardiff, Cardiff, United Kingdom · 10 investments in United Kingdom Life Science startups

Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Debt Financing
  • Geography: United Kingdom, Australia, United States

Investor stats

  • Total investments: 237
  • Round size: Seed $360k–$3.3M; Debt Financing $18k–$4.1M
  • Lead/follow: 60% lead, 40% follow
  • Last fund: May invest from a new fund soon — raised $25M in 2018

Portfolio highlights

  • IQ Endoscopes — Fully Disposable Endoscopes for General Medical Use. A successful initial investment funding round completed, we are seeking future funding to take the IQ Scope to market.
  • MeOmics Technology — MeOmics Technology is a biotech company with a focus on improving the diagnosis and treatment of mental health illnesses. The company operates in the manufacturing industry and has a team of 9 employees. The team includes experts in Neuronal Cell Biology and Neuropsychopharmacology. The company's mission is to leverage technology to enhancethe understanding and treatment of mental health conditions.
  • Bond Digital Health — Bond Digital Health is a technology company developing end-to-end digital connectivity for the point-of-care diagnostics market. Developed by founders Ian Bond and Dave Taylor and originally designed as a patient self-management tool, Bond’s digital technology was remodeled to meet the needs of a client - a world-renowned innovator in point-of-carediagnostics and the lateral flow industry. The client required a digital platform consisting of a patient-facing mobile app and cloud data management for their new quantitative diagnostic test for chronic lung disease. They shared their experiences of working with us with a collaborator company who quickly commissioned Bond to develop a similar product for chronic wound care. Others in the lateral flow industry recognised that an affordable, compliant and scalable solution was available highlighting a huge unmet need in an expanding market. Bond is working in strategic partnerships with key industry leaders to create the next generation of digitally connected lateral flow diagnostics that provide an elevated user experience and enhanced real-time decision-making through the power of data aggregation and data analytics.Our regulatory strategy ensures that the solutions we create are secure, reliable and compliant with regulatory standards, making us a trusted partner to leaders in human health, animal health and agri-food globally.In Bond Digital Health we believe that collaborative working is the only way to tackle some of the major health challenges the world is nowadays facing. Our technology brings the life sciences industry closer together to create solutions that improve the lives of millions.Let’s make a difference together!
Show all investments...

IQ Capital
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 9 investments in United Kingdom Life Science startups

IQ Capital is a Cambridge & London-based VC firm that invests in ‘deep tech’ companies capable of dominating their respective markets on a global scale. Initial investments at Seed and Series A range from £0.5m to £10m, with capacity for follow-on investment up to £30m through the Growth Fund. The team has achieved over 30 exits including toApple, Huawei, Google and Oracle.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 198
  • Round size: Seed $1.3M–$13M; Series A $4.5M–$44M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • Virti — Discover how our Immersive Learning Platform powers impactful & engaging learning experiences to transform enterprise workplace training.
  • Nyobolt — Nyobolt develops high-power energy storage systems based on advanced lithium-ion battery technology designed for rapid charging and sustained high performance. The company focuses on battery systems that enable very fast energy replenishment, supporting applications where downtime needs to be minimized. Its technology combines specialized anodematerials, cell design, battery management systems, and power electronics to achieve high charge and discharge rates. The platform is used in sectors such as robotics, data centers, industrial equipment, and electric mobility where consistent high power delivery is required. It also develops integrated energy solutions that support demanding workloads like automated logistics systems and high-performance computing infrastructure. Nyobolt’s approach emphasizes optimizing cycle life, thermal stability, and energy density for repeated fast charging environments.
  • Imperagen — Imperagen combines AI, QM/physics-based simulations, and high throughput lab testing to deliver true, verified enzyme improvements faster with lower cost.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 9 investments in United Kingdom Life Science startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 317
  • Round size: Series A $6.6M–$65M; Series B $10M–$109M; Series C $12M–$100M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • Biosyntia — Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology.By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds byfermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We partner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow.Biosyntia is located at the Novo Nordisk Foundation (NNF) Center for Biosustainability in Hørsholm, 25 kilometers north of Copenhagen.
  • Comet Biorefining — Comet Biorefining is a leading provider of sustainable high-quality cost-competitive cellulosic glucose technology for applications in renewable biofuels and biochemicals. The company’s proprietary technology allows for the conversion of wood, wheat straw, bagasse, corn stover and other agricultural waste materials into high purity cellulosicglucose syrup. These non-food sources offer lower cost and price stability when compared to food sugar sources such as corn or sugar cane. Demonstrated at 5 dry tons per day scale, Comet is focusing on commercial scale up and development of commercial partnerships with applications in renewables industries.
  • Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Show all investments...

GM&C Life Sciences Fund
VC Fund · Alderley Edge, Cheshire, United Kingdom · 7 investments in United Kingdom Life Science startups

The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Italy, Germany

Investor stats

  • Total investments: 33
  • Round size: Seed $65k–$936k; Series A $1.8M–$4.1M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • SurgaColl — SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien,the company aims to become a leader in the field of regenerative medical devices.
  • Acea Health — Acea Health is a digital healthcare company developing an application called Flynotes - a new digital consent platform. Flynotes analyses a number of factors, including the patient’s background, to deliver personalised risks and benefits. Flynotes aims to be the go-to solution for consent in healthcare. .
  • Nexus Labs (Surgical Teaching) — Nexus Labs is an interactive learning resource for medical students.
Show all investments...

Selvedge Venture
VC Fund · London, England, United Kingdom · 7 investments in United Kingdom Life Science startups

Selvedge Venture operates as a venture capital firm investing for impact in age-related medical conditions.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Life Science
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, Singapore

Investor stats

  • Total investments: 14
  • Round size: Seed $1.4M–$9.6M; Pre-Seed $1.1M–$2.5M; Series A $3.5M–$30M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
  • Mesh Bio — We enable digital transformation of care delivery through clinical workflow automation and predictive analytics, built on gold standard clinical guidelines and best practices.
  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Show all investments...

24 Haymarket
VC Fund · London, England, United Kingdom · 7 investments in United Kingdom Life Science startups

24Haymarket is an investment network which included several highly-experienced private equity and venture capital investors, seasoned entrepreneurs, and senior operators. Investing up to £5 million in growth companies in the UK and Europe. They invested their own capital in direct alignment with entrepreneurs and actively support their growthagenda and join the board of the companies in which they invest. Since inception in 2011, 24Haymarket has invested in more than 50 high-growth businesses.

Show more...

Investment focus

  • Industry: Health Care, Software, Information Technology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 104
  • Round size: Seed $714k–$3.8M; Series A $1.6M–$16M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • DrDoctor — We envision a remote-first healthcare system which meets demand without sacrificing care quality, delivered via our Patient Engagement Platform
  • DefiniGEN — Generate metabolic disease phenotypes in primary-like human cells using the best-in-class human iPSC differentiation platform. Find out more here!
  • Kelda Technology — Kelda Technology is a British clean tech business that develops water-in-air shower products that halve water usage and water heating costs through patented shower technology. Kelda Technology has adapted cutting edge automotive and aerospace technology to produce a revolutionary “water-in-air” shower system that halves water use without any lossin performance. Water is broken into droplets to form a comfortable spray which is accelerated using a globally patented jet-type nozzle. Not only does it halve water costs, but also halves associated heating costs.The Kelda shower system holds appeal for a wide range of sectors, including gym and leisure, hotels and accommodation providers, healthcare, and maritime – all industries where water efficiency is key. The product has completed in-market validation and commercial trials, is in manufacture and the company has already signed installation deals with some of the largest leisure operators in the UK and Latin America.Kelda Technology was recently chosen as one of the top 30 cleantech companies in the world at the New Energy Start-Up awards 2016 and was this week shortlisted by the UK Business Angels Association for Best Investment in a Disruptive Tech Business.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Syncona Partners LLP
VC Fund · London, England, United Kingdom · 7 investments in United Kingdom Life Science startups

Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 62
  • Round size: Seed $1.8M–$17M; Series A $17M–$110M; Series B $24M–$170M
  • Lead/follow: 58% lead, 42% follow

Portfolio highlights

  • Apini Therapeutics — Apini is a creating novel small chemical two most prevalent types of inflammatory bowel disease.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
  • Re-Aim Therapeutics — Re‑Aim Therapeutics is a UK‑based biotech start‑up developing functional cures for T cell–mediated autoimmune diseases by selectively depleting pathogenic T‑cell subsets. Its lead asset, REA‑001, is a monoclonal antibody designed to potently and precisely eliminate disease‑causing type‑17 T cells, aiming to reset the immune system and achievedurable, treatment‑free remission in multiple autoimmune conditions.
Show all investments...

Techstart Ventures
VC Fund · Belfast, Belfast, United Kingdom · 6 investments in United Kingdom Life Science startups

Techstart Ventures is a first-cheque investor for extraordinary founders pursuing uncapped global opportunities.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, Ireland, United States

Investor stats

  • Total investments: 162
  • Round size: Seed $249k–$3.9M; Pre-Seed $100k–$1.6M
  • Lead/follow: 45% lead, 55% follow

Portfolio highlights

  • Gigged.AI — Fill skill gaps using our on-demand talent network. Get AI-powered, real-time visibility over your employee and agent capabilities to power internal mobility.
  • Product Guru — Although there has been a significant change of pace in the technology used within the retail sector, the process of finding the products that drive the market has really remained at a stand-still. With more and more small, specialist suppliers driving innovation in the sector, it has been harder than ever for buyers to be able to consider alloptions.
  • Cloudsmith — Cloudsmith is the only universal, cloud-native solution for software artifact management and software supply chain security. Start your free trial today.
Show all investments...

Scottish Enterprise
VC Fund · Glasgow, Glasgow City, United Kingdom · 6 investments in United Kingdom Life Science startups

Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Grant, Seed
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 360
  • Round size: Seed $375k–$3.9M; Grant $119k–$4.3M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Pneumagen — Pneumagen focuses on developing glycan targeted carbohydrate-binding modules (CBMs) as a new universal therapeutic modality for the treatment of respiratory tract infections (RTIs) and cancer. Founded in 2016, the Company is a spin-out from the University of St Andrews in Scotland and has access to world-class scientific expertise and capabilitiesin glycobiology.
  • Trojan Energy — Trojan Energy support the roll-out of its on-street flat and flush electric vehicle charging points, which aims to solve the issue for vehicle owners who do not have access to off-street parking.
  • Smart Green Shipping — smart green shipping alliance. economically, socially and environmentally superior shipping solutions.
Show all investments...

Kindred Capital
VC Fund · London, England, United Kingdom · 6 investments in United Kingdom Life Science startups

A new model for Venture Capital where every founder we back becomes a co-owner of the fund

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 112
  • Round size: Seed $1.5M–$16M; Series A $7.9M–$35M; Series B $13M–$73M
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • Paddle — The revenue engine powering payments for n8n, Letterboxd & AdGuard. One platform that handles subscription billing, payments and compliance.
  • how.fm — Training software for better onboarding processes and digital store floor management. Train staff with no effort and language barriers.
  • Scarlet — Continuous compliance
Show all investments...

Angels in MedCity
VC Fund · London, England, United Kingdom · 6 investments in United Kingdom Life Science startups

Angels in MedCity is a partnership between MedCity, London Business Angels and Angels4LifeSciences. The programme aims to introduce new people to investing and investing in the healthcare/life sciences sector via investor workshops and introduce business angels to investment opportunities from highly-selected and trained companies.With aparticular focus on drug therapies, digital health and medical device technologies, Angels in MedCity brings potential investors together with life sciences experts in a programme aimed at both people who are new to investing and experienced investors who have little or no experience in the life sciences sector. The aim is to build investor understanding in the life sciences sector and support life sciences companies to gain funding to commercialise their ideas.Angels in MedCity has created a community of investors supported through a programme of investor workshops. Using case studies and tips from experienced investors in the field, the workshops explain how to identify and structure a good deal in the life sciences sector, as well as provide expert advice on tax breaks and legal issues.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Angel
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 18
  • Round size: Seed $458k–$880k
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
  • Clustermarket — The intuitive lab management system for all academic research facilities and industrial laboratories that need to efficiently manage equipment bookings.
  • DynamX Medical — DynamX Medical has developed a reliable and inexpensive precancer screening system for rapid tissue biopsy analysis that can be operated point-of-care by nurses.
Show all investments...

Future Planet Capital
VC Fund · London, England, United Kingdom · 6 investments in United Kingdom Life Science startups

Brilliant Ideas. Brilliant People. Brilliant Minds.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 168
  • Round size: Seed $670k–$7.3M
  • Lead/follow: 7% lead, 93% follow
  • Last fund: Likely still investing — raised $23M in 2022

Portfolio highlights

  • Nourished — At Nourished we create innovative. personalised nutrition stacks that are truly unique to you. Vegan, waste-free and always made to order.
  • NeoVac — NeoVac is creating revolutionary, unique and proprietary next-generation lipid nanoparticles to enable better RNA vaccines and treatments for various diseases.
  • K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
Show all investments...

Newable Private Investing
VC Fund · London, England, United Kingdom · 6 investments in United Kingdom Life Science startups

Newable: Helping over 20,000 businesses thrive annually with tailored financial products, advice, and flexible workspace solution

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 103
  • Round size: Seed $196k–$3.9M; Series A $1.3M–$5.2M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Weldfast — Weldfast is a manufacturer and supplier of welding consumables, abrasives, chemicals, premium gas equipment, and safety products.
  • NuVision — NuVision™ is a spin-out company from the University of Nottingham, incorporated July 2014. The company was established to commercialise high quality and affordable biotherapies for treating ‘front of the eye’ disease and trauma. Dr Andrew Hopkinson, the Principal Research Fellow in Academic Ophthalmology, Division of Clinical Neuroscience at theUniversity of Nottingham, founded NuVision™. The business is co-owned by the founders, Dr Andrew Hopkinson (Chief Scientific Officer), Professor Harminder Dua (co-founder), the directors Mr Byran Lister (CEO) and Dr Helen Shaw (Chairman), and the University of Nottingham.
  • RAB Microfluidics — We diagnose early signs of failure in lubricated machinery and prevent equipment failure using our patented microfluidic technology and AI technology.
Show all investments...

Archangels
VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 6 investments in United Kingdom Life Science startups

Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 85
  • Round size: Seed $1.3M–$3.9M; Series A $1.6M–$8.3M
  • Lead/follow: 54% lead, 46% follow

Portfolio highlights

  • BioCaptiva — BioCaptiva develops liquid biopsy technology devices to diagnose and monitoring to detect cancers.
  • Bioliberty — Engineering the future of physical and occupational therapy.
  • Earth Blox — Earth Blox is a paradigm shift for teaching Earth observation skills to everyone from children to university students & professionals.
Show all investments...

APEX Ventures
VC Fund · Vienna, Wien, Austria · 5 investments in United Kingdom Life Science startups

APEX Ventures is a deep-tech and medical-focused venture capital firm.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United Kingdom, Austria

Investor stats

  • Total investments: 53
  • Round size: Seed $1.3M–$8M; Pre-Seed $511k–$9.1M; Series A $2.2M–$22M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
  • HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
  • TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
Show all investments...

IP Group
VC Fund · London, England, United Kingdom · 5 investments in United Kingdom Life Science startups

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Australia

Investor stats

  • Total investments: 193
  • Round size: Seed $393k–$7.6M; Series A $2M–$23M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — raised $125M in 2014

Portfolio highlights

  • Barocal — Barocal is a Zero-carbon refrigeration pioneer.
  • Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
  • Kynos Therapeutics — Leading an inflammation revolution
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Northstar Ventures
VC Fund · Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom · 5 investments in United Kingdom Life Science startups

Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.

Show more...

Investment focus

  • Industry: Software, Health Care, E-Commerce
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Indonesia

Investor stats

  • Total investments: 199
  • Round size: Seed $39k–$2.2M; Series A $851k–$10M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • H2CHP — H2CHP's Free Piston Engine Technology enables your transition to green energy with the reliability & confidence of fuel flexibility.
  • NunaBio — NunaBio operates as a privately-owned specialist DNA development company. NunaBio engaged in CRO (Contract Research Organizations) and CDMO (Contract Development and Manufacturing Organisation) activities.
  • MySalesCoach — MySalesCoach offers Despite overwhelming evidence that sales coaching has the greatest impact on rep development and success, managers typically devote less than 5% of their time to coaching a team that craves and deserves coaching to reach their full potential.
Show all investments...

Scottish Investment Bank
VC Fund · Glasgow, Glasgow City, United Kingdom · 5 investments in United Kingdom Life Science startups

Speak with our Entrepreneurship and Investment teams, who can help you find sources of finance, engage with funders and secure investment to grow your business.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 208
  • Round size: Seed $327k–$3.1M; Series A $1.6M–$7M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
  • IOTech — Discover IOTech Systems. Deploy, manage, and scale AI-driven, data-rich industrial systems at the edge with our open edge data platform.
  • Pneumagen — Pneumagen focuses on developing glycan targeted carbohydrate-binding modules (CBMs) as a new universal therapeutic modality for the treatment of respiratory tract infections (RTIs) and cancer. Founded in 2016, the Company is a spin-out from the University of St Andrews in Scotland and has access to world-class scientific expertise and capabilitiesin glycobiology.
Show all investments...

Maven Capital Partners
VC Fund · Glasgow, Glasgow City, United Kingdom · 5 investments in United Kingdom Life Science startups

Maven is one of the UK's leading private equity and investment firms. We provide essential capital and expertise to help businesses unlock their potential.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 202
  • Round size: Seed $655k–$5.3M; Series A $2.2M–$25M
  • Lead/follow: 73% lead, 27% follow

Portfolio highlights

  • Bright — Bright Network has a range of graduate careers available. Whatever the sector you want to go into Bright Network will help you find your dream job.
  • ProofID — We are identity experts. We manage all aspects of your IAM program, from design and deployment, through to optimisation and ongoing support.
  • Guru Systems — Intelligent technology for the future of heat. Guru Systems provides market-leading hardware and data analytics platforms for heat networks, gas boilers and heat pumps. Our technology improves the performance of these systems for residential developers, heat suppliers, customers and our planet.
Show all investments...

Epidarex Capital
VC Fund · Bethesda, Maryland, United States · 5 investments in United Kingdom Life Science startups

Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 48
  • Round size: Seed $531k–$8.5M; Series A $2.6M–$38M; Series B $2.4M–$55M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Leucid Bio — CAR T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers.
  • Epsilogen — IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor.
  • Harness Therapeutics — Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currentlyhard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies.
Show all investments...

SR One
VC Fund · Cambridge, Massachusetts, United States · 5 investments in United Kingdom Life Science startups

SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 192
  • Round size: Series A $3.7M–$100M; Series B $15M–$114M; Series C $22M–$175M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Arch Oncology — Formerly Known as Vasculox. Tioma is an immuno-oncology company developing anti-CD47 antibodies for the treatment of solid and hematologic cancers. The company's functionally diverse antibodies represent a new class of checkpoint inhibitors that harness both the adaptive and innate immune responses.
  • Aileron Therapeutics — Aileron Therapeutics - ALRN-6924 - myelopreservation
  • AGTC — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

Deepbridge Capital
VC Fund · Chester, Cheshire, United Kingdom · 5 investments in United Kingdom Life Science startups

Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Australia, Singapore

Investor stats

  • Total investments: 86
  • Round size: Seed $152k–$2.6M; Series A $2M–$15M
  • Lead/follow: 72% lead, 28% follow
  • Last fund: Likely still investing — raised $1.4M in 2022

Portfolio highlights

  • HeadBox — HeadBox connects corporate event planners with 100,000+ unique, inspiring, iconic, and creative spaces worldwide for meetings and events.
  • Touch Biometrix — Welcome at Touch Biometrix. Find out more about The Future of Fingerprint Biometrics!
  • Spotlight Pathology — Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.
Show all investments...

11.2 Capital
VC Fund · San Francisco, California, United States · 4 investments in United Kingdom Life Science startups

In physics, 11.2 km/s is the escape velocity from Earth's gravity. They focus on emerging technologies such as AI, cybersecurity, robotics, quantum, new space, computational therapeutics, synthetic biology. ​They believe great people are leading indicators of a company's success. 11.2 Capital’s technical background, operationalexperience, and a strong network of amazing advisors and international partners particularly in Asia deliver a unique set of resources to entrepreneurs. While they are happy to help companies across the full range of early-stage company questions, areas where they concentrate include technical recruiting, partnerships (OEM and distribution partnerships for smart hardware companies, data partnerships for data-driven healthcare companies), customer introductions (CISO introductions for security companies, provider introductions for healthcare companies), and follow-on financings.

Show more...

Investment focus

  • Industry: Software, Information Technology, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 57
  • Round size: Seed $1M–$12M; Series A $7.3M–$26M; Series B $15M–$53M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Noetik — Noetik is an AI-native biotechnology company. Our mission is to leverage advanced machine learning methods to discover and develop cancer immunotherapies.
  • Mantle — Mantle is an engineering and manufacturing company that has developed metal 3D printing technology to produce high-resolution parts that meet the critical needs of applications from automotive and aerospace to consumer product design and prototyping.
  • CryptoNumerics — HIPAA, GDPR and Data Residency requirements restrict your ability to conduct data science. CryptoNumerics removes these restrictions. CryptoNumerics enables you to create privacy protected datasets with quantifiable privacy risk. In addition, you can build statistical and machine learning models that protect people’s privacy. Our team consists ofengineers and visionaries with previous experience in C-Level roles at Fortune 500 companies, founding teams of venture backed growth stage start-ups, and accomplished R&D leaders.
Show all investments...

AlbionVC
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

AlbionVC supports visionary founders and technologies with long-term capital and scale-up know-how. Founded in 1996, it was amongst the first to back leading global success stories such as Booking.com, Egress, Quantexa and Oviva. With £1bn in AUM and over 100 exits successfully realised, it funds venture breakthroughs that drive real outcomes forfounders, investors and society. AlbionVC is the technology investment arm of Albion Capital Group, which is authorised and regulated by the Financial Conduct Authority. For more information please visit: https://albion.vc/

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Series A, Seed
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 167
  • Round size: Seed $2.2M–$13M; Series A $3.8M–$20M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • Oviva — Oviva is digitizing the treatment of type 2 diabetes and obesity through a unique behavior change platform.They have developed unique, personalised behaviour change programmes that combine smartphone app and learning portals to support dietitian-led behaviour change for conditions such as type 2 diabetes and complex obesity. Their approach allowspatients to achieve a better health outcome without having to attend clinic appointments, whilst saving health systems significant sums by preventing the development of complications related to these health conditions.Oviva was founded in 2013 and is based in London, England.
  • uMotif — uMotif provides the most modern eCOA/ePRO and eConsent platform designed to power clinical and real-world research.
  • Neurofenix — Neurofenix understands the challenges stroke survivors face. We offer at-home stroke therapy services covered by Medicare with a dedicate virtual therapist.
Show all investments...

Cambridge Innovation Capital
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 4 investments in United Kingdom Life Science startups

As a team, we have a passion for science and its potential to drive change. Through our expertise and our position in one of the country's most powerful science and technology ecosystems, we're able to identify and support the most promising entrepreneurs in knowledge intensive businesses and help them achieve their vision.With our financial backing and expert guidance, we're excited to enable the pioneers in life sciences and deep tech to create world-leading companies whose unique ideas bring financial success and global impact.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 100
  • Round size: Seed $2.5M–$31M; Series A $2M–$73M; Series B $8.5M–$65M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Immutrin — Immutrin is a biotechnology company developing next‑generation antibody therapies designed to clear systemic amyloid deposits and reverse amyloidosis, this company lead asset targets ATTR cardiomyopathy, a severe and progressive form of amyloidosis, and its antibody represents a potential best‑in‑class treatment engineered to selectively andspecifically remove established amyloid fibrils.
  • Trent AI — Trent AI creates AI applications and agent security management software. It aids in risk assessment and mitigation in systems utilizing autonomous or semi-autonomous software agents. The company's technology monitors agent activity across APIs, tools, and workflows. It continuously assesses security posture via iterative scanning andcontextual understanding of system architectures.
  • BeyondMath — AI-first approach to simulating the physical world
Show all investments...

Oxford Capital
VC Fund · Oxford, Oxfordshire, United Kingdom · 4 investments in United Kingdom Life Science startups, 6 in the past 12 months

Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 141
  • Lead/follow: no public data

Portfolio highlights

  • Egregious — Egregious is an advanced research & intelligence lab established to defend humans from AI and provides narrative intelligence solutions across the public and private sectors to protect organisations and online users from malign influence using AI-driven data acquisition, insights, and engagement.
  • Arcube — We make sure all travellers, frequent and infrequent, make the most of travel loyalty programs, using our data-driven approach, airlines can understand their customers and provide hyper-personalised offerings to boost value and retention.Arcube uses a data-driven approach to make the most of airline loyalty programs for both frequent andinfrequent flyers. Our software allows airlines to understand their customers and provide hyper-personalised offerings to boost value and retention at no extra cost to the airline.
  • FinCrime Dynamics — Our mission is to help make the world’s financial system safer through rapid deployment of effective AI for financial crime analytics, enabled by enriched synthetic data that captures the dynamics of fraud and money laundering and loads them into tailor-made scenarios that explore diverse threats that financial organisations are exposed to.Thisgoal has taken us to the forefront of Synthetic Data and Fincrime Analytics, and we are proud to have in our team people that have helped shape the state-of-the-art of these fields.Keywords: Finacial services, AML, Synthetic Data, Fintech, Machine learning, Big data, Simulation, Fraud Analytics, Compliance
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Google Ventures
VC Fund · Mountain View, California, United States · 4 investments in United Kingdom Life Science startups

GV supports innovative founders moving the world forward.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 1110
  • Round size: Seed $1.1M–$16M; Series A $6M–$100M; Series B $15M–$121M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $100M in 2014

Portfolio highlights

  • Cord Project — Cord is incredibly simple, incredibly fast voice messaging that lets you chat with one friend or shout to a whole group of friends. Start chatting for free on iPhone or Android now.
  • Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
  • Cambridge Epigenetix — CEGX develops products for academia and industry, democratizing step-changes in accuracy and cost.
Show all investments...

SFC Capital
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Pre-Seed, Seed
  • Geography: United Kingdom, United States, Canada

Investor stats

  • Total investments: 488
  • Round size: Seed $127k–$2M; Pre-Seed $164k–$839k
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — raised $1.9M in 2019

Portfolio highlights

  • Sages — Biodegradeable, non-polluting, low-impact and vibrant dyes extracted from food waste.
  • Traknova — Traknova provides an AI-powered fleet management platform that helps companies track, manage, and protect vehicles and mobile assets. The platform offers real-time GPS tracking, live monitoring, and telematics data to give operators constant visibility over fleet movements and status. Users can access an intuitive dashboard with historical tripinformation, engine status, and alerts for events such as geofence breaches or unauthorized use. Traknova also supports integrated hardware, including tracking devices and online cameras, to strengthen asset security and streamline recovery when issues arise. The system is designed for fleets across industries, such as service businesses and vehicle rental operators, that need clearer scheduling, better time management, and improved operational control. By consolidating these tools into one platform, Traknova enables data-led fleet planning and day-to-day decision-making.
  • GNOSIS Health — Gnosis Health is a digital healthcare platform specializing in artificial intelligence and wearable technology for chronic disease management.
Show all investments...

Brandon Capital
VC Fund · Melbourne, Victoria, Australia · 4 investments in United Kingdom Life Science startups

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed, Series B
  • Geography: Australia, United Kingdom, United States

Investor stats

  • Total investments: 69
  • Round size: Seed $673k–$6.7M; Series A $4.9M–$115M; Series B $6.4M–$68M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — raised $210M in 2019

Portfolio highlights

  • Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
  • OncoRes Medical — OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue.OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leadingresearchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system.With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.
  • NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
Show all investments...

Advent Life Sciences
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 70
  • Round size: Series A $5.5M–$51M; Series B $21M–$105M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Cyted — Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. Our technologies use AI and novel biomarkers to improve patient outcomes.
  • Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

Angels 5K
VC Fund · Winchester, Hampshire, United Kingdom · 4 investments in United Kingdom Life Science startups

Southern Angel Investors Club, combining Surrey investors Club & Angels 5K, are entrepreneurs who understand what new businesses need.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Medical
  • Stage:Seed, Angel
  • Geography: United Kingdom

Investor stats

  • Total investments: 26
  • Round size: Seed $79k–$1.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Celixir — Celixir is a developer of regenerative medicines created to change the lives of patients in need. The company's medicines consists of iMP cells, platelet lysate and PML cells to treat patients with ischaemic heart disease, injured tendons near the surface of the skin and mild to moderate heart failure respectively, enabling medical researchersto discover breakthrough medicines that aim to change the standard of medical care for patients.
  • Novastone Media — Novastone enables instant chat across mobile and web to move customer conversations from email. Novastone’s white label chat solutions, built by financial industry experts, deliver on all these requirements, seamlessly moving organisations’ most valuable relationships from the inbox into a chat conversation.
  • Geektastic — Geektastic guarantees hiring teams only meet high calibre candidates. Our technical code challenges quickly identify the most talented software engineers.
Show all investments...

Playfair Capital
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

Playfair is a sector agnostic fund focused exclusively on pre-seed investing. Based in London, Playfair invests across the UK and Europe with an intentionally high conviction, low volume approach: making six investments a year out of its third $70m fund and preserving time, capital and resource to help companies post-investment. Our 78% Series Agraduation rate is ~3x industry average. Playfair has backed 100+ companies since 2013, including Thought Machine, Orca AI, Protex AI, StackOne and Nory.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, E-Commerce
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 138
  • Round size: Seed $1M–$7.6M; Pre-Seed $700k–$3.1M; Series A $2.7M–$19M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • auryx — Turning audible sound into health insights using AI
  • Wassist — Wassist is a platform for building AI-powered WhatsApp agents that help businesses automate sales, customer support, and marketing directly inside WhatsApp.
  • Passionfruit — Join hundreds of the best startups around the world and use Passionfruit to hire freelance marketing specialists on-demand.
Show all investments...

Formic Ventures
VC Fund · San Francisco, California, United States · 4 investments in United Kingdom Life Science startups

Formic Ventures is a diversified venture capital firm that makes early-stage investments in biotechnology startups focused on human longevity as well as technology startups and companies that make human lives more meaningful.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Biopharma
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Hong Kong

Investor stats

  • Total investments: 39
  • Round size: Seed $1.3M–$12M; Series A $17M–$61M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • SonoThera — Explore therapeutic ultrasound for non-invasive, targeted genetic medicine delivery that improves precision and biodistribution. Learn more.
  • cheMastery — Echo handles repetitive tasks with accuracy and precision, allowing your chemists to tackle high-value challenges.
  • Biogenesis — Clinical research platform tailored towards industry sponsors, clinical research sites & patients
Show all investments...

Octopus Ventures
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 387
  • Round size: Seed $2.1M–$13M; Series A $3.2M–$21M; Series B $7.5M–$48M
  • Lead/follow: 57% lead, 43% follow
  • Last fund: May invest from a new fund soon — raised $101M in 2019

Portfolio highlights

  • Turtl — Create personalized interactive content experiences that excite, engage and convert your audience with Turtl's intuitive content software.
  • Sprout.ai
  • Minimum — Take control of your organization's carbon accounting and management with granular, robust and auditable emissions data.
Show all investments...

Verve Ventures
VC Fund · Zug, Zug, Switzerland · 4 investments in United Kingdom Life Science startups

Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: Switzerland, Germany, France

Investor stats

  • Total investments: 273
  • Round size: Seed $1.4M–$12M; Series A $2.6M–$18M; Series B $4.2M–$45M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: Likely still investing — raised $66M in 2022

Portfolio highlights

  • Kiutra — We provide cryogen-free cooling systems that simplify low-temperature research. Our solutions offer fast cooldowns, automated control and millikelvin performance ideal for quantum technologies and material science.
  • Sleepiz — Sleepiz is a Zürich based startup with the aim to enable the medical community to take healthcare into the home environment. Sleepiz provides an easy and comfortable to use solution with a device that is simply placed on the bedside table. The device operates in a non-contact fashion and measures movements originating from heart contractions andbreathing patterns as well as body motions with medical grade accuracy.By making use of wireless millimeter wave technology, sensor fusion and artificial intelligence Sleepiz will in the future not only able to diagnose sleep disorders, but also to perform long-term monitoring. Thereby, the progression of chronic diseases can be monitored to allow faster intervention and better treatment.
  • Clinpal — Backed by over 30 years of scientific discovery and validation, Cambridge Cognition offers the end-to-end platform for CNS clinical trials.
Show all investments...

O2h Ventures
VC Fund · 4 investments in United Kingdom Life Science startups

Transforming UK biotech breakthroughs into impact. o2h Ventures offers SEIS/EIS and growth-stage funds to back visionary teams from seed to clinical success.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Hungary

Investor stats

  • Total investments: 39
  • Round size: Seed $603k–$7.5M; Series A $1.9M–$25M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Neurocentrx — Neurocentrx is a specialty pharma company, developing and in-licensing products in pain, palliative care, psychiatry and mood disorders.
  • BiVictriX Therapeutics — BiVictriX is a rapidly emerging UK biotechnology company applying a novel approach to develop safer, more effective cancer therapies.
  • Botanical Ventures Limited — Botanical Ventures Limited is a privately held company based in London, United Kingdom, and has been incorporated since 2017. The company brings together a diverse range of industries — including financial services, asset tokenization, mining operations, real estate, biotechnology, and botanical ventures — with a focus on building real-world valuethrough innovation and cross-sector expertise.Co-founded by Alexander Thomas Dover and Nicolas-André Borel, Botanical Ventures Limited operates with a vision to connect traditional industries with emerging technologies. While Alexander leads the company’s strategic direction, Nicolas-André serves as Chief Operating Officer, playing a key role in driving operational growth and cross-border initiatives.Registered under UK company law, Botanical Ventures is committed to long-term, sustainable development and creating new opportunities across both established and frontier markets.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Dementia Discovery Fund
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

SV Health Investors is a specialist healthcare fund manager, investing across multiple stages and sectors. Our goal is to transform healthcare one investment at a time.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 51
  • Round size: Seed $5.9M–$20M; Series A $7M–$77M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: May invest from a new fund soon — raised $337M in 2018

Portfolio highlights

  • Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
  • Endlyz Therapeutics — ndLyz Therapeutics, Inc. is developing disease-modifying therapeutics which restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease (PD) and other dementias.
  • Violet Therapeutics — Violet Therapeutics is a healthcare company that operates in stealth mode.
Show all investments...

Mercia Fund Managers
VC Fund · Henley In Arden, Warwickshire, United Kingdom · 4 investments in United Kingdom Life Science startups

Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Hungary

Investor stats

  • Total investments: 136
  • Round size: Seed $196k–$2M; Series A $2M–$14M
  • Lead/follow: 67% lead, 33% follow
  • Last fund: May invest from a new fund soon — last raise in 2013

Portfolio highlights

  • Sen — Sen's vision is to democratize space using video to inform, educate, inspire and benefit all humanity. Sen's mission is to stream real-time videos from space to billions of people, gathering news and information about Earth and space and making it universally accessible.
  • Gentronix — Gentronix is a contract research organisation (CRO) providing a wide range of screening and safety services, including genetic toxicology screening and regulatory genotoxicity studies.
  • Haystack — Giving techies the tools to uncover, explore and discover the tech landscape with full anonymity - showcasing opportunities that match their interests, values and tech stack.
Show all investments...

Beltrae Partners
VC Fund · Belfast, Belfast, United Kingdom · 4 investments in United Kingdom Life Science startups

Independent Corporate Finance Advisors & Private Equity Investors

Show more...

Investment focus

  • Industry: Health Care, Life Science, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 4
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Neurovalens — Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and neurophysiology.Neurovalens has received support from Invest NI under the European Union’s Investment for Growth and Jobs Programme. The project, recorded on the ERDF beneficiaries’ website, will be implemented over the next one year, undertaking research anddevelopment activities aimed at improving the competitiveness of the business.
Show all investments...

Delin Ventures
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

We are partnering with remarkable entrepreneurs and scientists on the mission of our lives: elevating humanity.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, Germany, Hungary

Investor stats

  • Total investments: 31
  • Round size: Seed $1.3M–$9.2M; Series A $5.1M–$30M; Series B $15M–$100M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • Turbine — Turbine is virtualizing biological experiments with AI to accelerate drug discovery and enhance clinical translatability.
  • Agile Analog — Agile Analog is a company with a mission to transform the landscape of the Analog IP market space.
  • Athernal Bio — Athernal Bio is developing targeted immunotherapies to treat blood cancer precursor conditions before cancers become established.
Show all investments...

Molten Ventures
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

Molten Ventures is a leading British venture capital firm backing Europe’s highest-growth private technology companies. Our expert investment team stay ahead of the curve, identifying transformative trends and next-generation companies before they break through. We combine multiple pools of capital to invest at all stages of the businesslifecycle—from seed and early stage to growth and late stage—focusing on disruptive sectors like Spacetech, Fintech, and AI. Our strategy is simple: back bold ideas, scale them with capital and expertise, and unlock high-value exits—whether through strategic acquisitions, trade buy-outs, or IPOs. Since our 2016 IPO, we’ve delivered strong realised returns, reinvesting into the next wave of innovation—creating a virtuous cycle of growth and value.

Show more...

Investment focus

  • Industry: Software, Information Technology, Financial Services
  • Stage:Series A, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 227
  • Round size: Series A $3.2M–$31M; Series B $7.9M–$60M
  • Lead/follow: 52% lead, 48% follow
  • Last fund: May invest from a new fund soon — raised $6.1M in 2011

Portfolio highlights

  • XMOS — In 2005, a small team assembled to create a fast and flexible microcontroller that would enable designers to respond quickly to diversifying market demand. The first (XS1) and second (xcore-200) generation processors put unprecedented I/O capability (available through software for the first time) alongside significant DSP and controlprocessing – establishing XMOS as a name in the audio sector.The vision quickly shifted towards AI. Caught between two very different technical and commercial models, Graphcore was formed to focus on server-side AI, and XMOS continued the quest towards low-cost embedded intelligence (edge-AI). Most recently XMOS enabled voice to become mainstream, releasing the XVF3510 – a disruptive high-performance, low cost far-field 2-mic voice interface. This was followed up with xcore.ai – a new crossover processor for the AIoT that brings AI, DSP, control and I/O together in a single device.
  • Focal Point Positioning — FocalPoint's software enables reliable GNSS in urban environments, mitigating multipath and enabling advanced vehicle autonomy.
  • Mobile Travel Technologies — Mobile Travel Technologies (MTT) is the leading mobile travel technology specialist for airlines, hotels and travel intermediaries with an extensive customer base across the global travel industry.MTT’s advanced mobile travel platform powers some of the most successful and highest revenue generating mobile channels in the travel industry. As apioneer in this space having first launched mobile bookings for airlines in 2006, MTT has remained a first mover in mobile travel and has picked up many awards along the way for its successful, customer focused travel apps & mobile sites. MTT offers its clients unrivalled travel industry expertise, world-class mobile development, creative design, mobile usability expertise and a sophisticated mobile travel platform. MTT clients include Saudi Arabian Airlines (Saudia), the flag carrier for Kingdom of Saudi Arabia, LAN Airlines in Chile and TAM Airlines in Brazil (the LATAM Airlines Group), easyJet, transavia.com of the Air France KLM Group, Flybe, Jumeirah Group and Atlantis The Palm, Dubai.
Show all investments...

Ahren Innovation Capital
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

Ahren Innovation Capital is a World Changing Institution. A group of highly diverse, creative and original thinkers, at the cutting edge of their domains.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Biotechnology, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, United States, Israel

Investor stats

  • Total investments: 44
  • Round size: Seed $2.7M–$15M; Series A $10M–$58M; Series B $15M–$150M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • Ambi Robotics — AI-powered robotic parcel sorting solutions for shipping, ecommerce and logistics. Automate package handling with robotic sorting systems.
  • Rockley Photonics — Rockley is developing a comprehensive range of photonic integrated circuits and associated modules, sensors, and full-stack solutions. From next-generation sensing platforms specifically designed for mobile health monitoring and machine vision to high-speed, high-volume solutions for data communications, Rockley is laying the foundation for a newgeneration of applications across multiple industries. Rockley believes that photonics will eventually become as pervasive as micro-electronics, and it has developed a platform with the power and flexibility needed to address both mass markets and a wide variety of vertical applications.
  • Adrestia Therapeutics — Adrestia is developing therapeutics that work in an entirely new way – restoring the biological balance in damaged, diseased or dying cells
Show all investments...

Catapult Ventures
VC Fund · Leicester, Leicester, United Kingdom · 4 investments in United Kingdom Life Science startups

The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Israel

Investor stats

  • Total investments: 105
  • Round size: Seed $150k–$5.6M; Series A $1.6M–$26M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Path Robotics — We create manufacturing robots that autonomously scan, position, and weld your parts without the need for skilled welders or robot programmers.
  • Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
  • Anello Photonics — Anello Photonics is founded by pioneers in silicon photonics and inertial navigation. The patented Anello SiPhOG gyroscope offers an affordable mass-market sensor with true Optical Gyroscope performance. The company is headquartered in Silicon Valley and funded by leading venture capital firms.
Show all investments...

Northern Gritstone
VC Fund · Leeds, Leeds, United Kingdom · 4 investments in United Kingdom Life Science startups

Northern Gritstone is an investment firm focused on investing in advanced materials, energy, health technology and cognitive computation.

Show more...

Investment focus

  • Industry: Software, Electronics, Health Care
  • Stage:Seed, Series A, Series D
  • Geography: United Kingdom, Singapore

Investor stats

  • Total investments: 37
  • Round size: Seed $2.4M–$7.3M; Series A $2.5M–$27M; Series D $42M–$229M
  • Lead/follow: 65% lead, 35% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • AmpliSi
  • Iceotope — Iceotope has developed technology with a blank drawing board and an open mind. So when we look at conventional problems, we find unconventional solutions.Built around our liquid-cooling approach and shaped by an extensive portfolio of patents, we’ve proven what our technology can do for HPC and data centre applications - dramatically reducingenergy consumption, space and noise. But it’s just the start. We’re going to keep innovating, working toward a day when wasteful, inefficient air-cooling is a thing of the past. We have created a business to look forward, but we’re also proud of the heritage that British engineering is built on. Iceotope is delighted to own the Made in Sheffield mark to show our dedication to the area’s tradition of engineering excellence. With decades of technical, design and engineering experience, we’ve established Iceotope as a trusted partner at the forefront of liquid-cooling technology. Now we’re investing to make sure we stay there: refining our designs, improving performance and engineering new applications.
  • Imperagen — Imperagen combines AI, QM/physics-based simulations, and high throughput lab testing to deliver true, verified enzyme improvements faster with lower cost.
Show all investments...

Discovery Park
VC Fund · Sandwich, Kent, United Kingdom · 4 investments in United Kingdom Life Science startups, 10 in the past 12 months

Discovery Park is a thriving UK science park offering state-of-the-art lab space to rent and modern offices in Kent.

Show more...

Investment focus

  • Industry: Biotechnology, Life Science, Energy
  • Stage:Non-Equity Assistance, Pre-Seed, Seed
  • Geography: United Kingdom, Germany, United States

Investor stats

  • Total investments: 15
  • Round size: Pre-Seed $391k–$1.7M
  • Lead/follow: 87% lead, 13% follow

Portfolio highlights

  • MilaK — MilaK is using the latest biotechnology and precision fermentation to make next-generation products that help with immune and metabolic function, recovery, and long-term health. These products will make nutrition smarter, cleaner, and more accurate.
  • BlokBio — BlokBio offers AI-driven tools for efficient genomic data analysis and workflow automation in biotechnology research.
  • Veirulence — Virulence is creating a new class of antibacterial drugs called therapies that target virulence factors (VF).
Show all investments...

Martlet Capital
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 3 investments in United Kingdom Life Science startups

Martlet Capital is an early-stage investor based in Cambridge, providing patient capital to deep technology and life science startups with high growth potential. Investing in the future.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 54
  • Lead/follow: no public data

Portfolio highlights

  • Xampla — Xampla's natural plant polymer technology is the innovative technology powering materials to change the world with plastic-free replacements and more.
  • Infinitopes — Infinitopes is a cancer research organization whose mission is to strengthen the immune system so that it can stop metastases and save lives. The company's platform creates healthcare systems and therapy designs to integrate high-efficiency vector delivery systems with optimal tumor target identification technologies in early-stage clinicaltrials, allowing patients to prevent cancer and tumors from taking their lives
  • AllFocal Optics — AllFocal Optics revolutionizes display technology through groundbreaking nanophotonic solutions.
Show all investments...

Life Science VC funding in United Kingdom at a glance

Stats across 487 deals from 554 investors.

554
investors
in United Kingdom Life Science startups
487
deals
in United Kingdom Life Science startups
$3.7M
median round
in United Kingdom Life Science startups
44%
lead investors
lead at least one round
28%
Seed
most common funding stage

Access all 554 VC funds in United Kingdom Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science VC Funds in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 554 VC funds investing in United Kingdom Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists